Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hayashi, S.
Right arrow Articles by Nakachi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, S.
Right arrow Articles by Nakachi, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 459-464, Copyright © 1997 by Oxford University Press


ARTICLES

Two promoters in expression of estrogen receptor messenger RNA in human breast cancer

S Hayashi, K Imai, K Suga, T Kurihara, Y Higashi and K Nakachi
Department of Biochemistry, Saitama Cancer Center Research Institute, Japan.

The human estrogen receptor (ER) gene has recently been shown to transcribe two types of mRNA originating from two distinct promoters in mammary tumor cell lines, which encode the same protein. However, use of the two promoters has not been addressed in human breast cancer, which reveals a heterogeneity in terms of ER expression status and clinical characteristics. In this report, we investigated which promoter is responsible for the expression of ER in human mammary tumors by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis for discriminatory detection of the two transcripts in mammary tissues obtained from patients with breast cancer. First, the use of distinct promoters was confirmed in several mammary tumor cell lines by the present RT-PCR method. Secondly, expression levels of total ER mRNA and two types of mRNAs from the different promoters were analysed in tumor, surrounding tissue and normal tissue obtained from 12 patients with breast cancer, which showed various levels of ER protein. In tumors, levels of total ER mRNA and the mRNA transcribed from a distal promoter showed remarkable correlation to the ER protein levels with correlation coefficients 0.946 (P < 0.001) and 0.746 (P < 0.005), respectively. In contrast, mRNA from a proximal promoter showed no correlation to the ER protein levels. Our results indicate that the enhancement of the ER mRNA expression from the distal promoter plays an essential role in the mechanisms of overexpressing ER protein in human mammary tumors, implying that a tumor-specific regulation of ER expression involved use of the distal promoter.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. M. Gaudet, M. Campan, J. D. Figueroa, X. R. Yang, J. Lissowska, B. Peplonska, L. A. Brinton, D. L. Rimm, P. W. Laird, M. Garcia-Closas, et al.
DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3036 - 3043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. K. de Ostrovich, I. Lambertz, J. K. L. Colby, J. Tian, J. E. Rundhaug, D. Johnston, C. J. Conti, J. DiGiovanni, and R. Fuchs-Young
Paracrine Overexpression of Insulin-Like Growth Factor-1 Enhances Mammary Tumorigenesis in Vivo
Am. J. Pathol., September 1, 2008; 173(3): 824 - 834.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. Dip, S. Lenz, J.-P. Antignac, B. Le Bizec, H. Gmuender, and H. Naegeli
Global gene expression profiles induced by phytoestrogens in human breast cancer cells
Endocr. Relat. Cancer, March 1, 2008; 15(1): 161 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Madureira, R. Varshochi, D. Constantinidou, R. E. Francis, R. C. Coombes, K.-M. Yao, and E. W.-F. Lam
The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor {alpha} in Breast Cancer Cells
J. Biol. Chem., September 1, 2006; 281(35): 25167 - 25176.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Buterin, C. Koch, and H. Naegeli
Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells
Carcinogenesis, August 1, 2006; 27(8): 1567 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sasaki, L. Kotcherguina, A. Dharia, S. Fujimoto, and R. Dahiya
Cytosine-Phosphoguanine Methylation of Estrogen Receptors in Endometrial Cancer
Cancer Res., April 1, 2001; 61(8): 3262 - 3266.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
T. Yoshida, H. Eguchi, K. Nakachi, K. Tanimoto, Y. Higashi, K. Suemasu, Y. Iino, Y. Morishita, and S.-i. Hayashi
Distinct mechanisms of loss of estrogen receptor {{alpha}} gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors
Carcinogenesis, December 1, 2000; 21(12): 2193 - 2201.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.